Skip to main content
SpringerLink
Log in

Pharmacokinetic and Pharmacodynamic Considerations in Drug Therapy of Cardiac Emergencies

  • Review Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Abstract

In the drug therapy of cardiac emergencies, it is necessary to rapidly achieve therapeutic drug concentrations and adjust drug dose as the patient’s clinical status changes. Cardiac dysfunction is often present and may alter drug pharmacokinetics. Circulatory failure causes sympathetically mediated vasoconstriction in most tissues, with relative sparing of the brain and heart due to autoregulation. Blood flow to vasoconstricted tissues is reduced, and the available cardiac output is redistributed so that the heart and brain receive a greater fraction. Drug distribution to tissues is therefore slowed, and the initial concentration of drug in blood is higher when circulatory failure is present than when it is absent. This higher blood concentration is reflected by higher concentrations of drug in the brain and heart, which are relatively well perfused. Initial doses of many drugs need to be reduced in patients with circulatory failure to prevent cardiac or central nervous system toxicity.

Cardiac output is markedly diminished during cardiopulmonary resuscitation (CPR), but blood flow distribution is qualitatively similar to that of circulatory failure with spontaneous circulation. Pneumatic trousers increase lower extremity vascular resistance and may produce a similar redistribution of blood flow. Drug distribution during the use of CPR or pneumatic trousers should be similar to that of circulatory failure with spontaneous circulation, but few data are available to guide drug dosing during the use of these interventions. Animal data suggest that the central volume of distribution of some drugs during CPR may be as small as one-tenth of normal.

Drug metabolism in circulatory failure may be impaired by reduced hepatic blood flow resulting in decreased clearance of highly extracted drugs, or by hepatocellular dysfunction resulting in decreased clearance of poorly extracted drugs. Drug excretion may be impaired by reduced renal blood flow resulting in decreased filtration or secretion and increased reabsorption. The maintenance dose of many drugs must therefore be reduced in the presence of circulatory failure.

Intravenous drug administration is preferred in patients with circulatory failure. The central intravenous route is often convenient but must be used cautiously when administering potentially cardiotoxic drugs. Intratracheal administration appears to be a promising alternative for some drugs, such as adrenaline (epinephrine). Intracardiac injections are hazardous and offer no demonstrated advantage over other routes.

Interpretation of drug concentrations in blood during cardiac emergencies must take account of the degree of protein binding of drug. Increases in the acute phase reactant α1-acid glycoprotein may decrease the unbound concentration of highly extracted drugs or increase the total concentration of poorly extracted drugs. Heparin can displace drugs from albumin by increasing free fatty acid concentrations, but this appears to be an in vitro artefact. The site of drug sampling may also be important: arterial concentrations of drug may greatly exceed venous concentrations during the distribution phase due to tissue uptake of drug.

Most antiarrhylhmic drugs have half-lives of at least several hours and require many hours to reach a steady-state blood concentration when administered as a constant rate intravenous infusion. Therapeutic blood concentrations of such drugs can be achieved more rapidlv by administering a loading dose consisting of I or more intravenous bolus doses or rapid infusions. Catecholamines have half-lives of several minutes, so a loading dose is not required. The application of pharmacokinetic and pharmacodynamic considerations to drug dosing in cardiac emergencies is illustrated by considering the use of several anti-arrhythmic agents [lignocaine (lidocaine), procainamide, verapamil, propranolol, bretylium], inotropic and vasopressor agents [noradrenaline (norepinephrine), adrenaline, dopamine, dobutamine, isoprenaline (isoproterenol)], and atropine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anderson, J.L.; Patterson, E.; Conlon, M.; Pasyk, S.; Pitt, B. and Lucchesi, B.R.: Kinetics of antifibrillatory effects of bretylium: Correlation with myocardial drug concentrations. American Journal of Cardiology 46: 583–592 (1980a).

    Article  PubMed  CAS  Google Scholar 

  • Anderson, J.L.; Patterson, E.; Wagner, J.G.; Johnson, T.A.; Lucchesi, B.R. and Bertram, P.: Clinical pharmacokinetics of intravenous and oral bretylium tosylate in survivors of ventricular tachycardia or fibrillation: Clinical application of a new assay for bretylium. Journal of Cardiovascular Pharmacology 3: 485–599 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Anderson, J.L.; Patterson, E.; Wagner, J.G.; Stewart, J.R.; Behm, H.L. and Lucchesi, B.R.: Oral and intravenous bretylium disposition. Clinical Pharmacology and Therapeutics 28: 468–478 (1980b).

    Article  PubMed  CAS  Google Scholar 

  • Anderson, P.; Bondesson, U. and Sylven, C.: Clinical pharmacokinetics of verapamil in patients with atrial fibrillation. European Journal of Clinical Pharmacology 23: 49–57 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Aronow, W.S.; Landa, D.; Plasencia, G.; Wong, R.; Karlsberg, R.P. and Ferlinz, J.: Verapamil in atrial fibrillation and atrial flutter. Clinical Pharmacology and Therapeutics 26: 578–583 (1979).

    PubMed  CAS  Google Scholar 

  • Barchowsky, A.; Shand, D.G.; Stargel, W.W.; Wagner, G.S. and Routledge, P.A.: On the role of alpha-1-acid glycoprotein in lignocaine accumulation following myocardial infarction. British Journal of Clinical Pharmacology 13: 411–415 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Bauer, L.A.; Brown, T.; Gibaldi, M.; Hudson, L.; Nelson, S.; Raisys, V. and Shea, J.P.: Influence of long-term infusions on lidocaine kinetics. Clinical Pharmacology and Therapeutics 31: 433–437 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Bax, N.D.S.; Tucker, G.T. and Woods, H.F.: Lignocaine and in-docyaninc green kinetics in patients following myocardial infarction. British Journal of Clinical Pharmacology 10: 353–361 (1980).

    PubMed  CAS  Google Scholar 

  • Bellet, S.; Roman, L.; Kistis, J.B. and Fleischmann, D.: Intramuscular lidocaine in the therapy of ventricular arrhythmias. American Journal of Cardiology 27: 291–293 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Benowitz, N.: Effect of cardiac disease on pharmacokinetics: Pathophysiologic considerations; in Benet et al. (Eds) The Pharmacokinetic Basis of Drug Treatment (In press, 1984).

  • Benowitz, N.; Forsyth, R.P.; Melmon, K.L. and Rowland, M.: Lidocaine disposition kinetics in monkey and man. II. Effects of hemorrhage and sympathomimetic drug administration. Clinical Pharmacology and Therapeutics 16: 99–109 (1974a).

    PubMed  CAS  Google Scholar 

  • Benowitz, N.; Forsyth, R.P.; Melmon, K.L. and Rowland, M.: Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model. Clinical Pharmacology and Therapeutics 16: 87–98 (1974b).

    PubMed  CAS  Google Scholar 

  • Benowitz, N.L. and Meister, W.: Pharmacokinetics in patients with cardiac failure. Clinical Pharmacokinetics 1: 389–405 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Benowitz, N.L. and Meister, W.: Clinical pharmacokinetics of lidocaine. Clinical Pharmacokinetics 3: 177–201 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Beregovich, J.; Reicher-Reiss, H. and Grishman, A.: Haemodynamic effects of isoprenaline in acute myocardial infarction. British Heart Journal 34: 705–710 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Beregovich, J.; Reicher-Reiss, H.; Kunstadt, D. and Grishman, A.: Hemodynamic effects of isoproterenol in cardiac surgery. Journal of Thoracic and Cardiovascular Surgery 62: 957–964 (1971).

    PubMed  CAS  Google Scholar 

  • Bishopm, R.L. and Weisfeldt, M.L.: Sodium bicarbonate administration during cardiac arrest. Journal of the American Medical Association 235: 506–509 (1976).

    Article  Google Scholar 

  • Bivins, H.G.; Knopp, R.; Tiernan, C; dos Santos, P.A.L. and Kallsen, G.: Blood volume displacement with inflation of antishock trousers. Annals of Emergency Medicine 409: 37–40 (1982).

    Google Scholar 

  • Brown, J.E.; Kitchell, B.B.; Bjornsson, T.D. and Shand, D.G.: The artifactual nature of heparin-induced drug protein-binding alterations. Clinical Pharmacology and Therapeutics 30: 636–643 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Brown, J.E. and Shand, D.G.: Therapeutic drug monitoring of antiarrhythmic agents. Clinical Pharmacokinetics 7: 125–148 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Camarata, S.J.; Weill, M.H.; Hanashiro, P.K. and Shubin, H.: Cardiac arrest in the critically ill. I. A study of predisposing causes in 132 patients. Circulation 44: 688–695 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Chadda, K.D.: Lichstein, E.; Gupta, P.K. and Choy, R.: Bradycardia hypotension syndrome in acute myocardial infarction. American Journal of Medicine 59: 158–164 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Chadda, K.D.; Lichstein, E.; Gupta, P.K. and Kourtesis, P.: Effects of atropine in patients with bradyarrhythmia complicating myocardial infarction. American Journal of Medicine 63: 503–510 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Chamberlain, D.A., Turner, P. and Sneddon, J.M.: Effects of atropine on heart-rate in healthy man. Lancet 2: 12–15 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Chandra, N.; Snyder, L.D. and Weisfeldt, J.L.: Abdominal binding during cardiopulmonary resuscitation in man. Journal of the American Medical Association 246: 351–353 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Chiou, W.L.; Lam, G.; Chen, M.L. and Lee, M.G.: Arterial-venous plasma concentration differences of six drugs in the dog and rabbit after intravenous administration. Research Communications in Chemistry, Pathology, and Pharmacology 32: 27–39 (1981).

    CAS  Google Scholar 

  • Chou, R.C. and Levy, G.: Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats. Journal of Pharmacology and Experimental Therapeutics 219: 42–48 (1981).

    PubMed  CAS  Google Scholar 

  • Chow, M.S.S.; Ronfeldt, R.A.; Hamilton, R.A.; Helmink, A. and Fieldman, A.: Effect of external cardiopulmonary resuscitation on lidocaine pharmacokinetics in dogs. Journal of Pharmacology and Experimental Therapeutics 244: 531–537 (1983).

    Google Scholar 

  • Chow, M.S.S.; Ronfeldt, R.A.; Ruffet, D. and Fieldman, A.: Lidocaine pharmacokinetics during cardiac arrest and external cardiopulmonary resuscitation. American Heart Journal 102: 799–801 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Clutter, W.E.; Bier, D.M.; Shah, S.D. and Cryer, P.E.: Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. Journal of Clinical Investigation 66: 94–101 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Cohen, H.C.; Gozo Jr, E.G.; Langendorf, R.; Kaplan, B.M.; Chan, A.; Pick, A. and Glick, G.: Response of resistant ventricular tachycardia to bretylium. Relation to site of ectopic focus and location of myocardial disease. Circulation 47: 331–340 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Cohen, L.S.; Rosenthal, J.E.; Homer Jr, D.W.; Atkins, J.M.; Mathews, O.A. and Sarnoff, S.J.: Plasma levels of lidocaine after intramuscular administration. American Journal of Cardiology 29: 520–523 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Cohn, J.N.; Tristani, F.E. and Khatri, I.M.: Cardiac and peripheral vascular effects of digitalis in clinical cardiogenic shock. American Heart Journal 78: 318–330 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Coltart, D.J. and Shand, D.G.: Plasma propranolol levels in the quantitative assessment of β-adrenergic blockade in man. British Medical Journal 3: 731–734 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Cooper, M.J. and Abinader, E.G.: Atropine-induced ventricular fibrillation: Case report and review of the literature. American Heart Journal 92: 225–227 (1979).

    Article  Google Scholar 

  • Crawford, M.H.; Ludden, T.M.; Kennedy, G.T.; Sodums, M.T.; O’Rourke, R.A. and Amon, K.W.: Hemodynamic effects of N-acetylprocainamide in heart disease. Clinical Pharmacology and Therapeutics 31: 459–465 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Dauchot, P. and Gravenstein, J.S.: Bradycardia after myocardial ischemia and its treatment with atropine. Anesthesiology 44: 501–518 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Davison, R.; Barresi, V.; Parker, M.; Meyers, S.N. and Talano, J.V.: Intracardiac injections during cardiopulmonary resuscitation. Journal of the American Medical Association 244: 1110–1111 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Davison, R.; Parker, M. and Atkinson Jr, A.J.: Excessive serum lidocaine levels during maintenance infusions: Mechanisms and prevention. American Heart Journal 104: 203–208 (1982).

    Article  PubMed  CAS  Google Scholar 

  • DeMots, H.; Rahimtoola, S.H.; McAnulty, J.H. and Porter, G.A.: Effects of ouabain on coronary and systemic vascular resistance and myocardial oxygen consumption in patients without heart failure. American Journal of Cardiology 41: 88–93 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Dhurandhar, R.W.; Teasdale, S.J. and Manon, W.A.: Bretylium tosylate in the management of refractory ventricular fibrillation. Canada Medical Association Journal 105: 161–173 (1971).

    CAS  Google Scholar 

  • Doherty, J.E. and Perkins, W.H.: Studies with tritiated digoxin in human subjects after intravenous administration. American Heart Journal 63: 528–536 (1962).

    Article  PubMed  CAS  Google Scholar 

  • Dominic, J.; McAllister Jr, R.G.; Kuo, C.S.; Reddy, C.P. and Surawicz, B.: Verapamil plasma levels and ventricular rate response in patients with atrial fibrillation and flutter. Clinical Pharmacology and Therapeutics 26: 710–714 (1979).

    PubMed  CAS  Google Scholar 

  • Dominic, J.A.; Bourne, D.W.A.; Tan, T.G.; Kirsten, E.B. and McAllister Jr, R.G.: The pharmacology of verapamil. III. Pharmacokinetics in normal subjects after intravenous drug administration. Journal of Cardiovascular Pharmacology 3: 25–38 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Duchin, K.L. and Schrier, R.W.: Interrelationship between renal haemodynamics, drug kinetics and drug action. Clinical Pharmacokinetics 3: 58–71 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Eichelbaum, M.; Somogyi, A.; von Unruh, G.E. and Dengler, H.J.: Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil. European Journal of Clinical Pharmacology 19: 133–137 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Elam, J.O.: The intrapulmonary route for CPR drugs; in Safar (Ed.) Advances in Cardiopulmonary Resuscitation, pp. 132–140 (Springer, New York 1977).

    Chapter  Google Scholar 

  • Esler, M.; Jackman, G.; Leonard, P.; Skews, H.; Bobik, A. and Korner, P.: Effect of norepinephrine uptake blockers on nor-epinephrine kinetics. Clinical Pharmacology and Therapeutics 29: 12–20 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Estes, J.W.: Clinical pharmacokinetics of heparin. Clinical Pharmacokinetics 5: 204–220 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Feely, J.; Wade, D.: McAllister, C.B.; Wilkinson, G.R. and Robertson, D.: Effect of hypotension on liver blood flow and lidocaine disposition. New England Journal of Medicine 307: 866–869 (1982a).

    Article  PubMed  CAS  Google Scholar 

  • Feely, J.; Wilkinson, G.R.; McAllister, C.B. and Wood, J.J.: Increased toxicity and reduced clearance of lidocaine by cimetidine. Annals of Internal Medicine 96: 592–594 (1982b).

    PubMed  CAS  Google Scholar 

  • FitzGerald, G.A.: Barnes, P.; Hamilton, C.A. and Dollery, C.T.: Circulating adrenaline and blood pressure: The metabolic effects and kinetics of infused adrenaline in man. European Journal of Clinical Investigation 10: 401–406 (1980).

    Article  PubMed  CAS  Google Scholar 

  • FitzGerald, G.A.; Hossman, V.; Hamilton, C.A.; Reid, J.L.; Davies, D.S. and Dollery, C.T.: Interindividual variation in kinetics of infused norepinephrine. Clinical Pharmacology and Therapeutics 26: 669–675 (1979).

    PubMed  CAS  Google Scholar 

  • Gadzinski, D.S.; White, B.C.; Hoehner, P.J.; Hoehner, T.; Krome, C and White, J.D.: Canine cerebral cortical blood flow and vascular resistance post cardiac arrest. Annals of Emergency Medicine 11: 58–63 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Gaffney, F.A.; Thal, E.R.; Taylor, W.F.; Bastian, B.C.; Weigelt, J.A.; Atkins, J.M. and Blomqvist, C.G.: Hemodynamic effects of medical anti-shock trousers (MAST garment). Journal of Trauma 21: 931–937 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Galeazzi, R.L.; Benet, L.Z. and Sheiner, L.B.: Relationship between the pharmacokinetics and pharmacodynamics of procainamide. Clinical Pharmacology and Therapeutics 20: 278–289 (1976).

    PubMed  CAS  Google Scholar 

  • Galster, A.D.; Clutter, W.E.; Cryer, P.E.; Collins, J.A. and Bier, D.M.: Epinephrine plasma thresholds for lipolytic effects in man. Journal of Clinical Investigation 67: 1729–1738 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Garret, E.R.; Green Jr, J.R. and Bailer, M.: Bretylium pharmacokinetics and bioavailabilities in man with various doses and modes of administration. Biopharmaceutics and Drug Disposition 3: 129–164 (1982).

    Article  Google Scholar 

  • George, C.F.; Conolly, M.E.; Fenyvesi, T.; Briant, R. and Dollery, C.T.: Intravenously administered isoproterenol sulfate doseresponse curves in man. Archives of Internal Medicine 130: 361–364 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Giacomini, K.M.; Swezey, S.E.; Giacomi, J.C and Blaschke, T.F.: Administration of heparin causes in vitro release of non-esterified fatty acids in human plasma. Life Science 27: 771–780 (1980).

    Article  CAS  Google Scholar 

  • Giardina, E.G.V.; Heissenbuttel, R.H. and Bigger, J.T.: Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure. Annals of Internal Medicine 78: 183–193 (1973).

    PubMed  CAS  Google Scholar 

  • Gillespie, T.A.; Ambos, H.D.; Sobel, B.E. and Roberts, R.: Effects of dobutamine in patients with acute myocardial infarction. American Journal of Cardiology 39: 588–594 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Goldberg, A.H.: Cardiopulmonary arrest. New England Journal of Medicine 290: 381–385 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Goldberg, L.I.; Hsieh, Y.Y. and Resnekov, L.: Newer catechol-amines for treatment of heart failure and shock: An update on dopamine and first look at dobutamine. Progress in Cardiovascular Disease 19: 327–340 (1977).

    Article  CAS  Google Scholar 

  • Gomeni, R.; Bianchetti, G.; Sega, R. and Morselli, P.L.: Pharmacokinetics of propranolol in normal healthy volunteers. Journal of Pharmacokinetics and Biopharmacology 5: 183–192 (1977).

    Article  CAS  Google Scholar 

  • Gonzales, R. and Scheinman, M.M.: Treatment of supraventricular arrhythmias with intravenous and oral verapamil. Chest 80: 465–470 (1981).

    Article  Google Scholar 

  • Gravenstein, J.S.; Andersen, T.W. and De Padua, C.B.: Effects of atropine and scopolamine on the cardiovascular system in man. Anesthesiology 25: 123–130 (1964).

    Article  PubMed  CAS  Google Scholar 

  • Greenberg, M.I.; Mayede, D.V.; Chrzanowski, R.; Brumwell, D.; Baskin, S.I. and Roberts, J.R.: Endotracheal administration of atropine sulfate. Annals of Emergency Medicine 11: 546–548 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Greenberg, M.I.; Roberts, J.R. and Baskin, S.I.: Endotracheal naloxone reversal of morphine-induced respiratory depression in rabbits. Annals of Emergency Medicine 9: 289–291 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Greenberg, M.I.; Roberts, J.R.; Krusz, J.C. and Baskin, S.I.: Endotracheal epinephrine in a canine anaphylactic shock model. Journal of the American College of Emergency Physicians 8: 500–503 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Greenspan, A.M.; Horowitz, L.N.; Spielman, S.R. and Josephson, M.E.: Large dose procainamide therapy for ventricular tachyarrhythmia. American Journal of Cardiology 46: 453–462 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Halkin, H.; Meffin, P.; Melmon, K.L. and Rowland, M.: Influence of congestive heart failure on blood levels of lidocaine and its active monodeethylated metabolite. Clinical Pharmacology and Therapeutics 17: 669–676 (1975).

    PubMed  CAS  Google Scholar 

  • Harrison, D.C.: Practical guidelines for the use of lidocaine. Prevention and treatment of cardiac arrhythmias. Journal of the American Medical Association 233: 1202–1204 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Hepner, G.W.; Vesell, E.S. and Tantum, K.R.: Reduced drug elimination in congestive heart failure. Studies using aminopyrine as a model drug. American Journal of Medicine 65: 271–276 (1978).

    Article  CAS  Google Scholar 

  • Higgins, C.B.; Vatner, S.F.; Franklin, D. and Braunwald, E.: Effects of experimentally produced heart failure on the peripheral vascular response to severe exercise in conscious dogs. Circulation Research 31: 186–194 (1972a).

    Article  PubMed  CAS  Google Scholar 

  • Higgins, C.B.; Vatner, S.F.; Millard, R.W.; Franklin, D. and Braunwald, E.: Alterations in regional hemodynamics in experimental heart failure in conscious dogs. Transactions of the Association of American Physicians 85: 267–275 (1972b).

    PubMed  CAS  Google Scholar 

  • Hoffman, J.R.: External counterpressure and the MAST suit: Current and future roles. Annals of Emergency Medicine 9: 419–421 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Holloway, E.L.; Polumbo, R.A. and Harrison, D.C.: Acute circulatory effects of dopamine in patients with pulmonary hypertension. British Heart Journal 37: 482–485 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Holzer, J.; Karliner, J.S.; O’Rourke, R.A.; Pitt, W. and Ross Jr, J.: Effectiveness of dopamine in patients with cardiogenic shock. American Journal of Cardiology 32: 79–84 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Jarnberg, P.O.; Bengtsson, L.; Ekstrand, J. and Hamberger, B.: Dopamine infusion in man, plasma calecholamine levels and pharmacokinetics. Acta Anaesthesiologica Scandinavica 25: 328–331 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Jose, A.D. and Taylor, R.R.: Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. Journal of Clinical Investigation 48: 2019–2031 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Jugdutt, B.I. and Lee, S.J.K.: Intravenous therapy with propranolol in acute myocardial infarction. Effects on changes in the S-T segment and hemodynamics. Chest 74: 514–521 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Kaplan, B.M. and Knott Jr, A.P.: Closed-chest cardiac massage for circulatory arrest. Archives of Internal Medicine 114: 5–12 (1964).

    Article  PubMed  CAS  Google Scholar 

  • Kates, R.E.; Keefe, D.L.D.; Schwartz, J.; Harapat, S.; Kirsten, E.B. and Harrison, D.C: Verapamil disposition kinetics in chronic atrial fibrillation. Clinical Pharmacology and Therapeutics 30: 44–51 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Koch-Weser, J.: Bretylium. New England Journal of Medicine 300: 473–477 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Koch-Weser, J. and Klein, S.W.: Procainamide dosage schedules, plasma concentrations, and clinical effects. Journal of the American Medical Association 215: 1454–1460 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Kornhauser, D.M.; Wood, A.J.J.; Vestal, R.E.; Wilkinson, G.R.; Branch, R.A. and Shand, D.G.: Biological determinants of propranolol disposition in man. Clinical Pharmacology and Therapeutics 23: 165–174 (1978).

    PubMed  CAS  Google Scholar 

  • Koup, J.R.; Greenblatt, D.J.; Jusko, W.J.; Smith, T.W. and Koch-Weser, J.: Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses. Journal of Pharmacokinetics and Biopharmacology 3: 181–192 (1975).

    Article  CAS  Google Scholar 

  • Kuhn, G.J.; White, B.C.; Sweetnam, R.E.; Mumey, J.F.; Rydesky, M.F.; Tintinalli, J.E.; Krome, R.L. and Hoehner, P.J.: Peripheral vs central circulation times during CPR: A pilot study. Annals of Emergency Medicine 10: 417–419 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Lam, G. and Chiou, W.L.: Arterial and venous blood sampling in pharmacokinetic studies: Propranolol in rabbits and dogs. Research Communications in Chemistry, Pathology and Pharmacology 33: 33–47 (1981).

    CAS  Google Scholar 

  • Leier, C.V.; Heban, P.T.; Huss, P.; Bush, C.A. and Lewis, R.P.: Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 58: 466–475 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Leier, C.V.; Unverferth, D.V. and Kates, R.E.: The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failure. American Journal of Medicine 66: 238–242 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Lelorier, J.; Grenon, D. and Latour, Y.: Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. Annals of Internal Medicine 87: 700–702 (1977).

    PubMed  CAS  Google Scholar 

  • Lepeschkin, E.; Mrachett, H.; Schroeder, G.; Wagner, R.; dePaula e Silva, P. and Raab, W.: Effect of epinephrine and norepinephrine on the electrocardiogram of 100 normal subjects. American Journal of Cardiology 5: 594–603 (1960).

    Article  PubMed  CAS  Google Scholar 

  • Lie, K.I.; Wellens, H.J. and Van Capelle, F.J.: Lidocaine in the prevention of primary ventricular fibrillation. New England Journal of Medicine 291: 1324–1326 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Lima, J.J.; Conti, D.R.; Goldfarb, A.L.; Golden, L.H. and Jusko, W.J.: Pharmacokinetic approach to intravenous procainamide therapy. European Journal of Clinical Pharmacology 13: 303–308 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Lima, J.J.; Goldfarb, A.L.; Conti, D.R.; Golden, L.H.; Bascomb, B.L.; Benedetti, G.M. and Jusko, W.J.: Safety and efficacy of procainamide infusions. American Journal of Cardiology 43: 98–105 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Mandel, W.; Hazukawa, H.; Danzing, R. and Marcus, H.S.: Evaluation of sinoatrial node function in man by overdrive suppression. Circulation 44: 59–64 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Mangiardi, L.M.; Hariman, R.J.; McAllister Jr, R.G.; Bhargava, V.; Surawicz, B. and Shabelai, R.: Electrophysiologic and hemodynamic effects of verapamil. Circulation 57: 366–372 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Marcus, F.I.: Use of digitalis in acute myocardial infarction. Circulation 62: 17–19 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Massumi, R.A.; Mason, D.T. and Amsterdam, E.A.: Ventricular fibrillation and tachycardia after intravenous atropine for treatment of bradycardias. New England Journal of Medicine 287: 336–338 (1972).

    Article  PubMed  CAS  Google Scholar 

  • McAllister Jr, R.G.; Bourne, D.W.A. and Dittert, L.W.: The pharmacology of verapamil. I. Elimination kinetics in dogs and correlation of plasma levels with effect on the electrocardiogram. Journal of Pharmacological and Experimental Therapeutics 202: 38–44 (1977).

    CAS  Google Scholar 

  • McDevitt, D.G. and Shand, D.G.: Plasma concentrations and the time-course of beta blockade due to propranolol. Clinical Pharmacology and Therapeutics 18: 708–713 (1975).

    PubMed  CAS  Google Scholar 

  • McDonald, J.L.: Systolic and mean arterial pressures during manual and mechanical CPR in humans. Critical Care Medicine 9: 382–383 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Mclnlyre, K.M.: Cardiovascular pharmacology: Part II; in Mc-Intyre and Lewis (Eds) Textbook of Advanced Cardiac Life Support, pp. IX-6 (American Heart Association, 1981).

  • Morton, H.J.V. and Thomas, E.T.: Effect of atropine on the heartrate. Lancet 2: 1313–1315 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Mueller, H.S.; Evans, R. and Ayres, S.M.: Effect of dopamine on hemodynamics and myocardial metabolism in shock following acute myocardial infarction in man. Circulation 57: 361–365 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Narang, P.K.; Adir, J.; Josselson, J.; Yacobi, A. and Sadler, J.: Pharmacokinetics of bretylium in man after intravenous administration. Journal of Pharmacokinetics and Biopharmacology 8: 363–372 (1980).

    Article  CAS  Google Scholar 

  • Noneman, J.W. and Rogers, J.F.: Lidocaine prophylaxis in acute myocardial infarction. Medicine 57: 501–515 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Ochs, H.R., Carstens, G. and Greenblatt, D.J.: Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol. New England Journal of Medicine 303: 373–377 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Paterson, J.W.: Human pharmacology: Comparison of intravenous isoprenalinc and salbutamol in asthmatic patients. Postgraduate Medical Journal 47(Suppl): 38–39 (1971).

    PubMed  CAS  Google Scholar 

  • Patwardhan, R.V.; Desmond, P.V.; Johnson, R.F.; Dunn, G.D.; Robertson, D.H.; Hoyumpa, A.M. and Schenker, S.: Effects of caffeine on plasma free fatty acids, urinary catecholamines, and drug binding. Clinical Pharmacology and Therapeutics 28: 398–403 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Pine, M.; Favrot, L; Smith, S.; McDonald, K. and Chidsey, C.A.: Correlation of plasma propranolol concentration with therapeutic response in patients with angina pectoris. Circulation 52: 886–893 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Prescott, L.F.; Adjepon-Yamoah, K.K. and Talbot, R.G.: Impaired lignocaine metabolism in patients with myocardial infarction and cardiac failure. British Medical Journal 1: 939–941 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Redding, J.S.; Asuncion, J.S. and Pearson, J.W.: Effective routes of drug administration during cardiac arrest. Anesthesiology and Analgesics 46: 253–258 (1967).

    CAS  Google Scholar 

  • Reiter, M.J.; Shand, D.G.; Aanonsen, L.M.; Wagoner, R.; McCarthy, E. and Pritchett, E.L.C.: Pharmacokinetics of verapamil: Experience with a sustained intravenous infusion regimen. American Journal of Cardiology 50: 716–721 (1982a).

    Article  PubMed  CAS  Google Scholar 

  • Reiter, M.J.; Shand, D.G. and Pritchett, E.L.C.: Comparison of intravenous and oral verapamil dosing. Clinical Pharmacology and Therapeutics 32: 711–720 (1982b).

    Article  PubMed  CAS  Google Scholar 

  • Reuning, R.H.; Sams, R.A. and Notari, R.E.: Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin. Journal of Clinical Pharmacology 13: 127–141 (1973).

    CAS  Google Scholar 

  • Roberts, J.R.; Greenberg, M.I. and Baskin, S.I.: Endotracheal epinephrine in cardiorespiratory collapse. Journal of the American College of Emergency Physicians 8: 515–519 (1979a).

    Article  PubMed  CAS  Google Scholar 

  • Roberts, J.R.; Greenerg, M.I.; Knaub, M.A.; Kendrick, Z.V. and Baskin, S.I.: Blood levels following intravenous and endotracheal epinephrine administration. Journal of the American College of Emergency Physicians 8: 53–56 (1979b).

    Article  PubMed  CAS  Google Scholar 

  • Romhilt, D.W.; Bloomfield, S.S.; Lipicky, R.J.; Welch, R.M. and Fowler, N.O.: Evaluation of bretylium tosylate for the treatment of premature ventricular contractions. Circulation 45: 800–807 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Rosenblum, R. and Frieden, J.: Intravenous dopamine in the treatment of myocardiac dysfunction after open-heart surgery. American Heart Journal 83: 743–748 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Routledge, P.A.; Shand, D.G.; Barchowsky, A.; Wagner, G. and Stargel, W.W.: Relationship between alpha one-acid glycoprotein and lidocaine disposition in myocardial infarction. Clinical Pharmacology and Therapeutics 30: 154–157 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Routledge, P.A.; Stargel, W.W.; Wanger, G.S. and Shand, D.G.; Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction. Annals of Internal Medicine 93: 701–704 (1980).

    PubMed  CAS  Google Scholar 

  • Rowland, M. and Tozer, T.N.: Clinical Pharmacokinetics: Concepts and Applications, p. 138 (Lea and Febiger, Philadelphia 1980).

    Google Scholar 

  • Salzer, L.B.; Weinrib, A.B.; Marina, R.J. and Lima, J.J.: A comparison of methods of lidocaine administration in patients. Clinical Pharmacology and Therapeutics 29: 617–624 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Scheinman, M.M.; Thorburn, D. and Abbott, J.A.: Use of atropine in patients with acute myocardial infarction and sinus bradycardia. Circulation 52: 627–633 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Schinz, A.; Schnelle, K.; Klein, G. and Blomer, H.: Time sequence of direct vascular and inotropic effects following intravenous administration of digoxin in normal man. International Journal of Clinical Pharmacology 15: 189–193 (1977).

    CAS  Google Scholar 

  • Schomerus, M.; Spiegelhaider, B.; Stieren, B. and Eichelbaum, M.: Physiological disposition of verapamil in man. Cardiovascular Research 10: 605–612 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Shand, D.G.; Nuckolls, E.M. and Oates, J.A.: Plasma propranolol levels in adults with observations in four children. Clinical Pharmacology and Therapeutics 11: 112–120 (1969).

    Google Scholar 

  • Shapiro, W.; Narahara, K. and Taubert, K.: Relationship of plasma digitoxin and digoxin to cardiac response following intravenous digitalization in man. Circulation 42: 1065–1072 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Silverberg, A.B.; Shah, S.D.; Haymond, M.W. and Cryer, P.E.: Norepinephrine: Hormone and neurotransmitter in man. American Journal of Physiology 234: 252–256 (1978).

    Google Scholar 

  • Singh, B.N.; Ellrodt, G. and Peter, C.T.: Verapamil: A review of its pharmacological properties and therapeutic use. Drugs 15: 169–197 (1978).

    Article  PubMed  Google Scholar 

  • Singh, J.B. and Kocot, S.L.: A controlled trial of intramuscular lidocaine in the prevention of premature ventricular contractions associated with acute myocardial infarction. American Heart Journal 91: 430–436 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Smith, T.W.: Drug therapy. Digitalis glycosides. New England Journal of Medicine 288: 719–724 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Smulyan, H.; Weinberg, S.E. and Howanitz, P.J.: Continuous propranolol infusion following abdominal surgery. Journal of the American Medical Association 247: 2539–2542 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Sonnenblick, E.H; Frishman, W.H. and LeJemtel, T.H.: Dobutamine: A new synthetic cardioactive sympathetic amine. New England Journal of Medicine 300: 17–22 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Stenson, R.E.; Constantino, R.T. and Harrison, D.C.: Interrelationships of hepatic blood flow, cardiac output, and blood levels of lidocaine in man. Circulation 43: 205–211 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Stone, P.H.; Amman, E.M.; Muller, J.E. and Braunwald, E.: Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. Annals of Internal Medicine 93: 886–904 (1980).

    PubMed  CAS  Google Scholar 

  • Sullivan, T.J.: Cardiac disorders in penicillin-induced anaphylaxis. Journal of the American Medical Association 248: 2161–2162 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Tern, G.; Vellani, C.W.; Higgins, M.R. and Doig, A.: Bretylium tosylate in treatment of refractory ventricular arrhythmias complicating myocardial infarction. British Heart Journal 32: 21–25 (1970).

    Article  Google Scholar 

  • Thomson, P.D.; Melmon, K.L.: Richardson, J.A.; Cohn, K.; Steinbrunn, W.; Cudihee, R. and Rowland, M.: Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Annals of Internal Medicine 78: 499–508 (1973).

    PubMed  CAS  Google Scholar 

  • Valentine, P.A.; Frew, J.L.; Mashford, M.L. and Sloman, J.G.: Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction. A double-blind study. New England Journal of Medicine 291: 1327–1331 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Voorhees, W.D.; Babbs, C.F. and Tacker, W.A.: Regional blood flow during cardiopulmonary resuscitation in dogs. Critical Care Medicine 8: 134–136 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Waller, E.S.: Pharmacoktnetic principles of lidocaine dosing in relation to disease state. Journal of Clinical Pharmacology 21: 181–194 (1981).

    PubMed  CAS  Google Scholar 

  • Webb, S.W.; Adgey, A.A.J. and Pantridge, J.F.: Autonomic disturbance at onset of acute myocardial infarction. British Medical Journal 2: 89–92 (1972).

    Article  Google Scholar 

  • Wilkinson, G.R. and Shand, D.G.: A physiologic approach to hepatic drug clearance. Clinical Pharmacology and Therapeutics 18: 377–390 (1975).

    PubMed  CAS  Google Scholar 

  • Woosley, R.L.; Shand, D.; Kornhauser, D.; Nies, A.S. and Oates, J.A.: Relation of plasma concentration and dose of propranolol to its effect on resistant ventricular arrhythmias. (Abstract.) Clinical Research 25: 262A (1977).

    Google Scholar 

  • Wyman, M.G.; Goldreyer, B.N.; Cannom, D.S.; Ludden, T.M. and Lalka, D.: Factors influencing procainamide total body clearance in the immediate postmyocardial infarction period. Journal of Clinical Pharmacology 21: 20–25 (1981).

    PubMed  CAS  Google Scholar 

  • Wyman, M.G.; Lalka, D.; Hammersmith, L.; Cannom, D.S. and Goldreyer, B.N.: Multiple bolus technique for lidocaine administration during the first hours of an acute myocardial infarction. American Journal of Cardiology 41: 313–317 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Zelis, R. and Mason, D.T.: Compensatory mechanisms in congestive heart failure — the role of the peripheral resistance vessels. New England Journal of Medicine 282: 962–964 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Zelis, R.; Mason, D.T. and Braunwald, E.: Partition of blood flow to the cutaneous and muscular beds of the forearm at rest and during leg exercise in normal subjects and in patients with heart failure. Circulation Research 24: 799–805 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Zener, J.C.; Kerber, R.E.; Spivack, A.P. and Harrison, D.C.: Blood lidocaine levels and kinetics following high-dose intramuscular administration. Circulation 47: 984–988 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Zito, R.A. and Reid, P.R.: Lidocaine kinetics predicted by in-docyanine green clearance. New England Journal of Medicine 298: 1160–1163 (1978).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Clinical Pharmacology and Toxicology, Department of Medicine, Hennepin County Medical Center and University of Minnesota Medical School, 701 Park Avenue South, Minneapolis, Minnesota, 55415, USA

    Paul Pentel

  2. Clinical Pharmacology Unit, Department of Medicine, San Francisco General Hospital and University of California, San Francisco, USA

    Paul Pentel, Neal Benowitz & Neal Benowitz

Authors
  1. Paul Pentel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neal Benowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pentel, P., Benowitz, N. Pharmacokinetic and Pharmacodynamic Considerations in Drug Therapy of Cardiac Emergencies. Clin Pharmacokinet 9, 273–308 (1984). https://doi.org/10.2165/00003088-198409040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198409040-00001

Keywords

Search

Navigation